Clinical progression of Alzheimer’s disease is characterized by impairment in cognition and function. The objective of the recent study published in the JPAD Journ Prevention Alzheiemr’s diseases is to assess the relationship between cognitive and functional impairment in mild Alzheimer’s… Continue Reading →
To facilitate disease-modifying clinical trials for Alzheimer’s Disease (AD), a blood-based amyloid-β (Aβ) biomarker, which can accurately detect an early pathological signature of AD at prodromal or preclinical stages, has been strongly desired, because it is simpler, less invasive and… Continue Reading →
© 2025 Aging-news